Vertex To Announce Second Quarter 2013 Financial Results On July 29
CAMBRIDGE, Mass. -- June 27, 2013
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second
quarter 2013 financial results on Monday, July 29, 2013 after the financial
markets close. The company will host a conference call and webcast at 5:00
The conference call will be webcast live and a link to the webcast may be
accessed from the “Vertex Events” page of Vertex’s website at www.vrtx.com. A
replay of the conference call and webcast will be archived on the company’s
website until August 5, 2013. To ensure a timely connection, it is recommended
that users register at least 15 minutes prior to the scheduled webcast.
Vertex creates new possibilities in medicine. Our team discovers, develops and
commercializes innovative therapies so people with serious diseases can lead
Vertex scientists and our collaborators are working on new medicines to cure
or significantly advance the treatment of hepatitis C, cystic fibrosis,
rheumatoid arthritis and other life-threatening diseases.
Founded more than 20 years ago in Cambridge, Mass., we now have ongoing
worldwide research programs and sites in the U.S., U.K. and Canada. Today,
Vertex has more than 2,000 employees around the world, and for three years in
a row, Science magazine has named Vertex one of its Top Employers in the life
sciences. Vertex’s press releases are available at www.vrtx.com.
Michael Partridge, 617-341-6108
Kelly Lewis, 617-961-7530
Zach Barber, 617-341-6470
Press spacebar to pause and continue. Press esc to stop.